Orion OYJ (OTCMKTS:ORINY) Issues Earnings Results

Orion OYJ (OTCMKTS:ORINY) issued its earnings results on Thursday. The company reported $0.37 earnings per share (EPS) for the quarter, Zacks reports. Orion OYJ had a net margin of 26.68% and a return on equity of 47.67%.

Orion OYJ Stock Performance

Shares of OTCMKTS ORINY opened at $37.99 on Friday. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.40 and a quick ratio of 1.58. The stock has a market capitalization of $10.72 billion, a P/E ratio of 18.62 and a beta of 0.10. Orion OYJ has a 1-year low of $25.95 and a 1-year high of $42.75. The business has a fifty day moving average price of $39.25 and a 200 day moving average price of $37.66.

Analysts Set New Price Targets

Separately, Danske cut shares of Orion OYJ from a “buy” rating to a “hold” rating in a research report on Thursday, January 15th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold”.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.